The disclosure of Covishield risk by AstraZeneca could lead to legal disputes in India.
According to The Telegraph, the vaccine’s manufacturer claimed in court filings that there was a chance the shot may occasionally cause thrombosis with thrombocytopenia syndrome (TTS), a condition that causes…